- Home
- EFR vs ORGO Comparison
EFR vs ORGO Comparison
Compare EFR & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFR
- ORGO
- Stock Information
- Founded
- EFR 2003
- ORGO 1985
- Country
- EFR United States
- ORGO United States
- Employees
- EFR N/A
- ORGO N/A
- Industry
- EFR Trusts Except Educational Religious and Charitable
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- EFR Finance
- ORGO Health Care
- Exchange
- EFR Nasdaq
- ORGO Nasdaq
- Market Cap
- EFR 372.9M
- ORGO 408.3M
- IPO Year
- EFR N/A
- ORGO N/A
- Fundamental
- Price
- EFR $12.90
- ORGO $4.02
- Analyst Decision
- EFR
- ORGO Strong Buy
- Analyst Count
- EFR 0
- ORGO 3
- Target Price
- EFR N/A
- ORGO $5.33
- AVG Volume (30 Days)
- EFR 88.6K
- ORGO 675.6K
- Earning Date
- EFR 01-01-0001
- ORGO 11-12-2024
- Dividend Yield
- EFR 9.43%
- ORGO N/A
- EPS Growth
- EFR N/A
- ORGO N/A
- EPS
- EFR 1.69
- ORGO N/A
- Revenue
- EFR N/A
- ORGO $455,038,000.00
- Revenue This Year
- EFR N/A
- ORGO $7.42
- Revenue Next Year
- EFR N/A
- ORGO $0.08
- P/E Ratio
- EFR $7.74
- ORGO N/A
- Revenue Growth
- EFR N/A
- ORGO 1.34
- 52 Week Low
- EFR $10.95
- ORGO $2.17
- 52 Week High
- EFR $13.29
- ORGO $4.71
- Technical
- Relative Strength Index (RSI)
- EFR 54.42
- ORGO 64.27
- Support Level
- EFR $12.80
- ORGO $3.76
- Resistance Level
- EFR $13.01
- ORGO $4.16
- Average True Range (ATR)
- EFR 0.09
- ORGO 0.30
- MACD
- EFR 0.01
- ORGO 0.06
- Stochastic Oscillator
- EFR 64.52
- ORGO 69.78
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of health care, industrial equipment, lodging and casinos, oil and gas, publishing, radio and television, telecommunications, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.